A structured review of the TriVerity Acute Infection and Sepsis Test, prepared to support a stakeholder decision on whether to adopt it in the surgical ICU.
These materials summarize research we conducted on TriVerity for surgical ICU use. They are shared for stakeholder review and discussion — no adoption decision has been made. A conflict-of-interest note regarding the manufacturer's involvement in the cited literature is included at the end of the decision aid's reference list.
The concise summary intended for circulation: proposed use cases, thresholds, and workflow fit. Fourteen numbered references, each with a one-line note on what it supports. Bracketed citations and DOIs are clickable within the PDF, and twelve of the fourteen references are open access.
The complete evidence review behind the decision aid: study-by-study appraisal of the published literature, confirmed cost figures from the CMS New Technology Add-on Payment rulemaking, and an appendix with eighteen clickable DOIs validated against Crossref.
References and DOIs are clickable within each PDF. Documents current as of August 2026.
